Karl Landsteiner University of Health Sciences important study center. Data published in New England Journal of Medicine. Krems (Austria), 23. November 2023: Results from a recently published phase II clinical trial of an immunotherapeutic agent (Tarlatamab) for the treatment of small cell lung cancer have demo.
EARLY GENETIC ANALYSIS OF ADVANCED AND METASTATIC BILIARY TRACT CANCER TO OPTIMIZE SECOND-LINE THERAPY New recommendations on current best treatment options favor targeted therapies for specific genetic alterations in tumor cells Krems (Austria), 21. September, 2023: Experts from Austria have now pub.
Research Team at the Karl Landsteiner University of Health Sciences develops novel protocol for studying isolated pairs of hippocampal neurons. Dedicated work honoured by cover page in Bio-protocol Journal. Krems (Austria), 29. August 2023 – Studying the complex interactions between synaptic nerve endings.
LATEST FINDINGS ON RARE DISEASE OF THE INNER EAR KL Krems, Harvard Medical School and Johns Hopkins University find striking volume changes in special structures of the auditory apparatus Krems, Austria, 03. August, 2023 – Elaborate 3D analysis of the inner ear now, for the first time, provide.
PRIMARY TUMOR OR METASTASIS? DEEP LEARNING AND RADIOMICS ALLOW PRECISE DIFFERENTIATION IN BRAIN TUMORS Krems (Austria), 18. January, 2023 – The distinction between primary tumors and metastases can be made quickly and accurately in brain tumors using radiomics and deep learning algorithms. This.